Arcus Biosciences Inc (NYSE:RCUS) Stock News, Headlines & Updates
Arcus Biosciences Inc Stock News from GuruFocus
- 1
Aug 21, 2024
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
Business Wire • 4:00pm
Aug 08, 2024
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
Business Wire • 4:00pm
Arcus Biosciences Inc (RCUS) Q2 2024 Earnings: Revenue Surpasses Estimates at $39M, GAAP EPS at -$1.02
GuruFocus Research • 3:48pm
Jul 25, 2024
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
Business Wire • 4:00pm
Jul 09, 2024
Arcus Biosciences Announces New Employment Inducement Grants
Business Wire • 4:00pm
Jul 08, 2024
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
Business Wire • 6:00pm
Jun 25, 2024
Arcus Biosciences Announces New Employment Inducement Grants
Business Wire • 4:00pm
Jun 11, 2024
Arcus Biosciences Announces New Employment Inducement Grants
Business Wire • 4:00pm
Jun 10, 2024
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
Business Wire • 8:00am
Jun 06, 2024
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Business Wire • 4:00pm
Jun 02, 2024
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
Business Wire • 8:00am
Jun 01, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news